11.2 Capital Founded 2013
Founders Shelley Zhuang
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 11
Rounds per year 1.38
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.21
Exits -
Key employees -
Stages of investment
Early Stage Venture
Seed
Areas of investment
Artificial Intelligence
Biotechnology
Health Care
Robotics
Software
Summary

11.2 Capital appeared to be the VC, which was created in 2014. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

Comparing to the other companies, this 11.2 Capital performs on 25 percentage points less the average number of lead investments. The average startup value when the investment from 11.2 Capital is 100-500 millions dollars. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2016. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 16 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.

This organization was formed by Shelley Zhuang. We also calculated 1 valuable employee in our database.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the 11.2 Capital, startups are often financed by Y Combinator, Felicis Ventures, Creative Destruction Lab. The meaningful sponsors for the fund in investment in the same round are Y Combinator, SV Angel, First Round Capital. In the next rounds fund is usually obtained by Y Combinator, Khosla Ventures, Data Collective DCVC.

Among the most popular portfolio startups of the fund, we may highlight Cruise Automation, Ginkgo BioWorks, Lucira Health. The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Genetics, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
CryptoNumerics
Analytics
Artificial Intelligence
Information Technology
Machine Learning
Privacy
Software
Seed
2M13 Mar 2019 Canada, Old Toronto
Hinge Health
Employee Benefits
Fitness
Health Care
Medical
Therapeutics
Wearables
Wellness
Seed
1M20 Jun 2016 Panama, San Francisco
Loop Genomics
Biotechnology
Genetics
Information Technology
Medical
Venture - Series Unknown
14 Apr 2016 United States, San Jose
Auransa
Artificial Intelligence
Biotechnology
Health Care
Pharmaceutical
Therapeutics
Series A
15M31 May 2017 United States, Palo Alto
Cruise
Automotive
Autonomous Vehicles
Robotics
Software
Transportation
Convertible Note
01 Apr 2014 Panama, San Francisco
Deep Genomics
Artificial Intelligence
Biotechnology
Genetics
Therapeutics
Seed
3M18 Nov 2015 Canada, Old Toronto
TigerGraph
Analytics
Big Data
Database
Real Time
Software
Seed
2M14 Nov 2013 United States, Redwood City
Hinge Health
Employee Benefits
Fitness
Health Care
Medical
Therapeutics
Wearables
Wellness
Series A
8M16 Jun 2021 Panama, San Francisco
Ginkgo Bioworks
Biopharma
Biotechnology
Chemical
Seed
120K16 Jul 2014 United Kingdom, Boston
Passage AI
Artificial Intelligence
Machine Learning
Software
Series A
7M16 Jun 2021 United States, Mountain View
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent 11.2 Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: